Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: A therapeutic cancer vaccine against GL261 murine glioma

Fig. 4

BLI of long-term surviving mice. The vaccinated mouse shown on the left in figure a underwent BLI at 99 days post-engraftment of GL261 cells; two control tumor-bearing mice are shown at the center and right. The vaccinated mouse shown on the right of figure b underwent BLI at 93 days post-engraftment with 2 × 104 GL261 cells; two control tumor-bearing mice are shown at the center and left. Both vaccinated, long-term surviving mice appeared to be disease-free

Back to article page